YOUR BROWSER IS OUT-OF-DATE.
We have detected that you are using an outdated browser. Our service may not work properly for you. We recommend upgrading or switching to another browser.
The first antibody-drug conjugates for Alzheimer's disease therapy
SONATA-BIS, NCN, 2024/54/E/NZ5/00373, 4 995 200 PLN
Dissecting the regulatory interplay between proteases and protein kinases in acute lymphoblastic leukemia using mass cytometry compatible activity-based probes for personalized diagnostics
OPUS, NCN, 2022/47/B/NZ5/02405, 3 304 800 PLN
read more
Dissecting cancer activome to develop new generation of antibody-drug conjugates
OPUS-LAP, NCN, 2020/39/I/NZ5/03104, 2 468 800 PLN
read more
Unraveling protease activation in stimulated CAR-T cells to identify new biomarkers for assessing their clinical efficacy
OPUS, NCN, 2023/49/B/NZ7/03915, 3 672 100 PLN